Imprecision of Urinary Iothalamate Clearance as a Gold-Standard Measure of GFR Decreases the Diagnostic Accuracy of Kidney Function Estimating Equations

American Journal of Kidney Diseases

Volumn 56, Issue 1, 2010, Pages 39-49

  Stevens, Lesley A ^b   Greene, Tom ^c   Van Lente, Frederick ^d  

^a Diana)   (United States)

^b Lucy)   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

creatinine; cystatin C; Gold standard; kidney function estimation equations; measured glomerular filtration rate

Indexed keywords

CREATININE; CYSTATIN C; INULIN; IOTALAMIC ACID; IOTALAMIC ACID I 125;

ADULT; ARTICLE; BLOOD SAMPLING; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DRUG CLEARANCE; FEMALE; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; GOLD STANDARD; HUMAN; INULIN CLEARANCE; KIDNEY CLEARANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IOTHALAMIC ACID; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; REFERENCE STANDARDS; STATISTICS AS TOPIC;

EID: 77953683329     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.02.347     Document Type: Article

References (24)

1. Rehberg P.B. Studies on kidney function: the excretion of urea and chlorine analysed according to a modified filtration-reabsorption theory. Biochem J 20 3 (1926) 461-482
2. 125I-sodium iothalamate in the determination of the glomerular filtration rate. Nucl Med (Stuttg) 6 3 (1967) 304-310
3. Rapoport A., and Husdan H. Endogenous creatinine clearance and serum creatinine in the clinical assessment of kidney function. CMAJ 99 4 (1968) 149-156
4. Grubb A., Simonsen O., Sturfelt G., Truedsson L., and Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218 5 (1985) 499-503
5. Knight E.L., Verhave J.C., Spiegelman D., et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65 4 (2004) 1416-1421
6. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 6 (1999) 461-470
7. Stevens L.A., Coresh J., Feldman H.I., et al. Evaluation of the Modification of Diet in Renal Disease Study equation in a large diverse population. J Am Soc Nephrol 18 10 (2007) 2749-2757
8. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51 3 (2008) 395-406
9. Ma Y.C., Zuo L., Chen J.H., et al. Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int 72 12 (2007) 1535-1542
10. Tidman M., Sjostrom P., and Jones I. A comparison of GFR estimating formulae based upon S-cystatin C and S-creatinine and a combination of the two. Nephrol Dial Transplant 23 1 (2008) 154-160
11. Levey A.S., Coresh J., Greene T., et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53 4 (2007) 766-772
12. Stevens L.A., Manzi J., Levey A.S., et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis 50 1 (2007) 21-35
13. Beck G.J., Berg R.L., Coggins C.H., et al. Design and statistical issues of the Modification of Diet in Renal Disease trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials 12 5 (1991) 566-586
14. Gassman J.J., Greene T., Wright Jr. J.T., et al. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol 14 7 suppl 2 (2003) S154-S165
15. Miller W.G., Myers G.L., Ashwood E.R., et al. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med 129 3 (2005) 297-304
16. 125I-iothalamate. Kidney Int 4 5 (1973) 346-349
17. 99mTc-DTPA, and inulin. The Modification of Diet in Renal Disease Study. Am J Kidney Dis 16 3 (1990) 224-235
18. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 4 (2006) 247-254
19. Lewis J., Greene T., Appel L., et al. A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension. J Am Soc Nephrol 15 12 (2004) 3175-3183
20. Kyhse-Andersen J., Schmidt C., Nordin G., et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40 10 (1994) 1921-1926
21. Levey A.S., Greene T., Schluchter M.D., et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 4 5 (1993) 1159-1171
22. Scott P.J., and Hurley P.J. Demonstration of individual variation in constancy of 24-hour urinary creatinine excretion. Clin Chim Acta 21 3 (1968) 411-414
23. Klahr S., Levey A.S., Beck G.J., et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330 13 (1994) 877-884
24. Wright Jr. J.T., Bakris G., Greene T., et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease results from the AASK trial. JAMA 288 19 (2002) 2421-2431